ArticleEuropean journal of pediatrics2025
Genetic variants and audiometric patterns in nonsyndromic enlarged vestibular aqueduct Chinese children with complete hearing loss.
Article in European journal of pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Enlarged vestibular aqueduct (EVA) is one of the most common inner ear malformations (IEMs) leading to hearing loss in children. Although its genetic and clinical characteristics have been studied, its manifestations in completely deaf children in China, especially those with or without incomplete partition type II (IP-II), are not yet fully understood. We conducted a comprehensive analysis of 123 pediatric EVA children with complete hearing loss. Participants were classified into isolated EVA (IEVA, n = 93) and IP-II with EVA (IP-II & EVA, n = 30) groups, with 30 age-, sex-, and hearing status-matched subjects with no IEMs. Evaluations included audiologic tests and genetic screening for common deafness-associated variants. Pure-tone audiometry revealed significantly lower hearing thresholds in IEVA ears compared to those with no IEMs (1 kHz: p < 0.001; 2 kHz: p = 0.005; pure-tone average: p = 0.013). Ai-bone gap (ABG) was more prevalent in IEVA than IP-II & EVA cases (p = 0.019). Acoustically evoked short latency negative response (ASNR) was detected in 66.67% of IEVA and 63.33% of IP-II & EVA ears, significantly higher than controls. Genetic screening of 52 patients revealed pathogenic variants in 66.03%, with SLC26A4 c.919-2A > G being the predominant mutation. Biallelic mutations were significantly more common in IP-II & EVA compared to IEVA patients (p = 0.022).
conclusionsEVA patients exhibit distinct audiometric patterns and genetic variants based on their inner ear morphology. The higher prevalence of biallelic SLC26A4 mutations in IP-II & EVA children suggests a stronger genetic component in this phenotype, potentially influencing clinical management strategies. WHAT IS KNOWN: • The genetic and clinical characteristics of patients with enlarged vestibular aqueduct (EVA) have been studied. However, its manifestations in completely deaf children in China, especially those with or without incomplete partition type II (IP-II), are not yet fully understood. WHAT IS NEW: • Isolated enlarged vestibular aqueduct (IEVA) patients demonstrated lower hearing thresholds but higher air-bone gap (ABG) rates compared to IP-II with EVA (IP-II & EVA) cases. The SLC26A4 c.919-2A > G mutation emerged as predominant, with biallelic mutations occurring more frequently in IP-II & EVA cases. These findings may guide clinical management strategies for affected children.
Indexed as
Identifiers
40906196What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.